Practitioner Review: Differential susceptibility theory: might it help in understanding and treating mental health problems in youth?

The review addresses whether differential susceptibility theory—conceptualising individual differences as variations in environmental sensitivity that operate for better and for worse—can help understand and treat youth mental health problems. Background literature shows substantial variability in how individuals respond to adversity (stress, life events) and to positive influences (support, interventions). Traditional diathesis-stress approaches emphasise vulnerability to negatives; differential susceptibility posits that some individuals are more sensitive to both negative and positive environmental inputs. The purpose and significance are to evaluate the theoretical frameworks, summarize empirical evidence across development, psychopathology, and interventions, and explore potential implications for clinical practice with children and adolescents.

The paper reviews three related frameworks: Differential Susceptibility Theory (evolutionary-developmental model proposing that both high and low sensitivity confer fitness advantages, supported initially by parenting and GxE studies); Biological Sensitivity to Context (focus on physiological reactivity—autonomic, adrenocortical, immune systems—shaped by early environments, emphasizing conditional adaptation); and Sensory Processing Sensitivity (a stable personality trait capturing depth of processing, low thresholds to stimulation, attention to subtleties, and behavioral inhibition). Proposed mechanisms span dopaminergic and serotonergic circuitry, amygdala reactivity, stress-response systems, and neural processes of attention, awareness, empathy, and depth of processing. Measurement approaches include: (1) candidate markers (biological/psychological) assessed in interaction designs showing for-better-and-for-worse moderation; (2) phenotypic questionnaires/observational measures (HSP/HSC, HSC-RS) indexing trait sensitivity; and (3) genetic/twin designs, notably MZ-twin difference GWAS to derive polygenic scores indexing environmental sensitivity. Evidence across developmental outcomes shows that sensitivity moderates effects of parenting and social contexts: difficult temperament and HSC/HSC-RS scores predict more negative outcomes with adverse parenting but better outcomes with positive parenting; neuroimaging markers in adolescent girls show differential associations of parent-child relationship quality and peer victimisation with depressive symptoms and emotion regulation. Genetic sensitivity polygenic scores moderate parenting effects on child emotional problems. Psychopathology studies (largely cross-sectional) link higher sensitivity with elevated anxiety/depression symptoms, autism traits/alexithymia, emotion regulation difficulties, lower life satisfaction, higher neuroticism, poorer physical health, burnout, and greater stress during COVID-19; shared genetic influences with neuroticism/low extraversion may underlie covariation. Intervention literature, though limited, suggests highly sensitive individuals may benefit more from positive interventions: school-based resilience and anti-bullying programs show larger gains for those high in sensitivity (with some sex-specific effects), and a genome-wide polygenic sensitivity score moderates CBT delivery-mode outcomes in child anxiety. The review highlights gaps: biases in sensitivity questionnaires toward negative items, limited longitudinal and clinical-diagnostic research, small predictive power of genetic indices, practical limits of physiological measures, and uncertainty over stability and subtypes (including potential vantage sensitivity).

This is a narrative practitioner review synthesizing theoretical frameworks and empirical findings from developmental, clinical, genetic, psychophysiological, neuroimaging, and intervention studies on environmental sensitivity/differential susceptibility. The authors summarize representative studies and meta-analytic observations from the existing literature; no systematic search strategy, inclusion/exclusion criteria, or quantitative meta-analysis are reported. No new data are collected or analyzed.

• Environmental sensitivity operates in a for-better-and-for-worse manner: more sensitive individuals show greater vulnerability under adverse conditions but also greater benefit in supportive or enriched contexts.
• Developmental outcomes: Higher child sensitivity (e.g., difficult temperament, HSC/HSC-RS scores) amplifies effects of parenting—negative parenting predicts more externalising/emotional problems, whereas positive/authoritative parenting predicts better social competence and fewer problems. Neurobiological sensitivity markers (e.g., cingulate/insula activation to social exclusion; amygdala–rVLPFC connectivity) in adolescent girls moderate associations between social contexts (parental relationship quality, peer victimisation) and depressive symptoms/emotion regulation in differential-susceptibility patterns.
• Genetic evidence: A polygenic score derived via MZ-twin difference GWAS indexes environmental sensitivity; high genetic sensitivity strengthens the impact of parenting on child emotional problems (more problems with negative parenting; fewer with positive parenting).
• Psychopathology associations: High sensitivity correlates with higher anxiety/depression symptoms, emotion regulation problems, autism traits, alexithymia, lower life satisfaction, higher neuroticism, poorer physical health, burnout, and greater stress responses (largely cross-sectional; causality unclear; shared genetics with neuroticism/low extraversion observed).
• Intervention response: Sensitivity moderates benefits from school-based programs (resilience, anti-bullying), with greater improvements for highly sensitive youths (some sex-specific patterns). A genome-wide polygenic sensitivity score moderates CBT delivery outcomes in child anxiety: children with high sensitivity scores achieved remission rates of 70.9% (individual CBT), 55.1% (group CBT), and 40.6% (brief parent-led CBT), whereas low-sensitivity children improved similarly across modalities.
• Clinical implications (provisional): Potential roles in psychoeducation (reframing from vulnerability to sensitivity), treatment planning (considering sensitivity when choosing intensity/delivery), resilience-building and environmental/systemic modifications, and relapse prevention planning.
• Significant gaps: Limited longitudinal/clinical-diagnostic studies, lack of validated clinical cut-offs for sensitivity, questionnaire bias toward negatives, modest predictive power of polygenic scores, and unclear mechanisms (including potential sensitivity subtypes such as vantage sensitivity).

The review suggests that differential susceptibility provides a complementary framework to diathesis-stress for understanding individual differences in youth mental health. By centering on environmental sensitivity, it explains why some young people fare worse under adversity yet benefit disproportionately from positive contexts and interventions. Preliminary evidence indicates that sensitivity may inform psychoeducation, help personalise intervention delivery (e.g., prioritising individual CBT for those with high sensitivity), and guide resilience-building and systemic environmental changes. However, translation to routine clinical practice is premature: measures lack clinical cut-offs and may be biased; evidence is mostly cross-sectional or non-clinical; genetic indices explain little variance; and mechanisms and potential subtypes are insufficiently understood. Addressing these gaps through longitudinal, clinically ascertained studies and improved measurement could enable sensitivity-informed prognostics and treatment tailoring, ensuring attention to both highly sensitive and less sensitive individuals (who may respond well across treatment types).

Differential susceptibility theory holds promise for advancing prevention and treatment in child and adolescent mental health by reframing individual differences as environmental sensitivity with for-better-and-for-worse effects. Current evidence indicates that higher sensitivity is linked to greater risk under adversity and greater benefit from positive environments and certain interventions, including potentially greater gains from higher-intensity, individualised therapies. Yet, direct clinical application is not warranted at present. Future work should develop balanced, clinically useful sensitivity measures (including cut-offs), strengthen genetic indices with larger samples, conduct longitudinal and clinical-diagnostic studies to establish predictive validity for onset and relapse, and elucidate mechanisms and subtypes (e.g., vantage sensitivity). Such advances could enable sensitivity-informed psychoeducation, personalised treatment selection, resilience-focused strategies, and robust relapse prevention.

• Predominantly cross-sectional, correlational evidence; limited longitudinal and life-course analyses of sensitivity and outcomes.
• Few studies in clinically diagnosed samples; reliance on self-report symptom measures reduces clinical applicability.
• Lack of clinically validated cut-offs for sensitivity; widely used HSP/HSC measures are biased toward negative items, potentially underestimating positive outcomes.
• Genetic polygenic sensitivity scores currently explain a small fraction of variance; require much larger samples for robust prediction.
• Physiological markers are informative but impractical for routine clinical use.
• Early-stage treatment-response literature; modest effects and need for replication; adult clinical evidence limited.
• Unclear mechanisms and potential subtypes (e.g., differential sensitivity to positives vs negatives); no measures to distinguish subtypes.
• Risk of misinterpretation: low sensitivity should not be conflated with poor treatment response; sensitivity should be one of multiple prognostic factors.